Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Dom

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Basic and Clinical Neuroscience|August 29, 2020
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position PaperAli Farhoudian, Alexander Baldacchino, Nicolas Clark, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 9, 2021
Mental health services during the first wave of the COVID-19 pandemic in Europe: Results from the EPA Ambassadors Survey and implications for clinical practiceMartina Rojnic Kuzman, Simavi Vahip, Andrea Fiorillo, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 9, 2023
The price of peace in our timeIrina Pinchuk, Bennett L Leventhal, Tsuyoshi Akiyama, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 16, 2026
Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term CarePavel Mohr, Geert Dom, Peter Falkai, et al.
BMC Health Services Research|March 12, 2022
System-level policies on appropriate opioid use, a multi-stakeholder consensusPatrice Forget, Champika Patullo, Duncan Hill, et al.
The International Journal of Social Psychiatry|June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 28, 2026
Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHDLisa I Horstman, Dora Koller, Judit Cabana-Domínguez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Addictive Behaviors|November 6, 2016
Childhood trauma exposure in substance use disorder patients with and without ADHDMaija Konstenius, Anders Leifman, Katelijne van Emmerik-van Oortmerssen, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Basic and Clinical Neuroscience|August 29, 2020
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position PaperAli Farhoudian, Alexander Baldacchino, Nicolas Clark, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 9, 2021
Mental health services during the first wave of the COVID-19 pandemic in Europe: Results from the EPA Ambassadors Survey and implications for clinical practiceMartina Rojnic Kuzman, Simavi Vahip, Andrea Fiorillo, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 9, 2023
The price of peace in our timeIrina Pinchuk, Bennett L Leventhal, Tsuyoshi Akiyama, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 16, 2026
Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term CarePavel Mohr, Geert Dom, Peter Falkai, et al.
BMC Health Services Research|March 12, 2022
System-level policies on appropriate opioid use, a multi-stakeholder consensusPatrice Forget, Champika Patullo, Duncan Hill, et al.
The International Journal of Social Psychiatry|June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 28, 2026
Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHDLisa I Horstman, Dora Koller, Judit Cabana-Domínguez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Addictive Behaviors|November 6, 2016
Childhood trauma exposure in substance use disorder patients with and without ADHDMaija Konstenius, Anders Leifman, Katelijne van Emmerik-van Oortmerssen, et al.
Pageof 13